GINS2 and neoplasm: Firstly, our results show that compared with nontumour tissues, the high expression of GINS2 in BLCA, BRCA, CHOL, COAD, ESCA, GBM, HNSC, KICH, KIRC, KIRP, LIHC, LUAD, LUSC, STAD, THCA, UCEC, CESC, READ, PCPG, ACC, DLBC, LAML, OV, SARC, SKCM, THYM, and UCS tissues indicates that GINS2 may be used as a tumour promoter in human cancer [22].